Leveraging the emirate’s advanced genomic infrastructure,
DoH, ADIO and GSK Collaborate on Oncology Multi-Omics Institute in Abu Dhabi

- The transformative initiative is set to accelerate oncology-focused genomic science and precision medicine in the region and beyond
- The institute seeks to contribute to the diversification and global representation in genomic research to ultimately improve outcomes for patients with cancer


